Performance Evaluation of a Urine-based Methylation Assay for Urothelial Carcinoma
Clinical trial NCT06912672 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06912672
- Sponsor
- Shanghai Epiprobe Biotechnology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-05-01
- Primary completion
- 2026-05-01
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.